There are suggestions that Anp32a may play important roles in the brain as the level of Anp32a is increased in Alzheimer’s disease and may be involved in the regulatory mechanism of affecting Tau phosphorylation and impairing the microtubule network and neurite outgrowth [40]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.